Actual Medicinal Product (AMP) Escitalopram 20mg tablets (Bristol Laboratories Ltd)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Suitable for use in MCAs, although use is likely to be off-label. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
No theoretical concerns with product. Anecdotal reports of use in MCAs for up to 6 months (low quality evidence).
- Provenance
-
This recommendation is based on the products Cipralex 20mg tablets (Lundbeck Limited) and escitalopram 20mg tablets (Amarox Limited).
- Generic
- Escitalopram
- Formulation
- Escitalopram 20mg tablets
-
Escitalopram
-
Escitalopram 20mg tablets
-
Escitalopram 20mg tablets (Bristol Laboratories Ltd)
-
-
Escitalopram 10mg orodispersible tablets sugar free